Major drug firm to reveal China bribes scandal
The chief executive of GlaxoSmithKline (GSK) is to admit to major failings in the pharma's Chinese operations, following allegations by the country's security ministry that the company took kick-backs and paid bribes to government officials.
Andrew Witty is set to use the company's second-quarter results next week to reveal that GSK's own investigation into allegations of a "huge economic scam" has uncovered evidence that senior executives in the country were involved in an orchestrated attempt to falsify invoices, pay sweeteners to third parties and siphon off payments.
It expects to face fines which could total tens of millions of euro, as well as criminal trials for the individuals involved. GSK is even worried that execution may be the final sanction.
Independent.ie Comments Facility
INM has taken the decision to remove the commenting facility on its online platform Independent.ie to minimise the legal risk to our business that arises from Ireland's draconian libel awards system.
We continue to look forward to receiving comments through direct email contact or via social media, some of which may still be featured on the website Independent.ie